Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 622-630

  Kondo, Yoko ^a   Arii, Shigeki ^a   Mori, Akira ^a   Furutani, Masaharu ^a   Chiba, Tsutomu ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL GROWTH; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; CAPILLARIES; CELL DIVISION; COLONIC NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LIVER NEOPLASMS; LYMPHOKINES; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033963827     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285:1182-1186, 1971.
2. Gimbrone, M., Leapman, S., Cotrans, R., and Folkman, J. Tumor dormancy in vitro by prevention of neovascularization. J. Exp. Med., 136: 261-276, 1972.
3. Gimbrone, M., Cotron, R., Leapman, S., and Folkman, J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl. Cancer Inst., 52: 413-427, 1974.
4. Knighton, D., Ausprunk, D., Tapper, D., and Folkman, J. Avascular and vascular phases of tumor growth in the chick embryo. Br. J. Cancer, 35: 347-356, 1977.
5. Folkman, J. Seminars in medicine of the Beth Israel Hospital. Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
6. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
7. Takahashi, Y., Cleary, K. R., Mai, M., Kitadai, Y., Bucana, C. D., and Ellis, L. M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin. Cancer Res., 2: 1679-1684, 1996.
8. Toi, M., Inada, K., Hoshina, S., Suzuki, H., Kondo, S., and Tominaga, T. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin. Cancer Res., 1: 961-964, 1995.
9. Mattern, J., Koomägi, R., and Volm, M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer, 73: 931-934, 1996.
10. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143: 1255-1262, 1993.
11. Berse, B., Brown, L. F., Water, L. V. D., Dvorak, H. F., and Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell, 3: 211-220, 1992.
12. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
13. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
14. Yeo, K. T., Wang, H. H., Nagy, J. A., Scioussat, T. M., Ledbetter, S. R., Hoogewerf, A. J., Zhou, Y., Masse, E. M., Senger, D. R., Dvorak, H. F., and Yeo, T. K. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effu-sions. Cancer Res., 53: 2912-2918, 1993.
15. Ferrara, N., and Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161: 851-858, 1989.
16. Dvorak, H. F., Dvorak, A. M., Manseau, E. J., Wiberg, L., and Churchill, W. H. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J. Natl. Cancer Inst., 62: 1459-1472, 1979.
17. Plate, K. H., Breier, G., Welch, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
18. Takahashi, Y., Tucker, S. L., Kitadai, Y., Koura, A. N., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-nega-tive colon cancer. Arch. Surg., 132: 541-546, 1997.
19. Akira, M., Shigeki, A., Masaharu, F., Koji, H., Yoshihisa, T., Takeo, M., Yoko, K., Manuel, J. G. R., and Masayuki, I. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model. Int. J. Cancer, 80: 738-743, 1999.
20. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Investig., 95: 1789-1797, 1995.
21. Ellis, L. M., Liu, W., and Wilson, M. Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation. Surgery (St. Louis), 120: 871-878, 1996.
22. Declan Fleming, R. Y., Ellis, L. M., Parikh, N. U., Liu, W., Staley, C. A., and Gallick, G. E. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase. Surgery (St. Louis), 122: 501-507, 1997.
23. Ellis, L. M., Staley, C. A., Liu, W., Declan Fleming, R. Y., Parikh, N. U., Bucana, C. D., and Gallick, G. E. Down-regulation of vascular growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. J. Biol. Chem., 273: 1052-1057, 1998.
24. Melyyk, O., Shuman, M. A., and Kim, K. J. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res., 56: 921-924, 1996.
25. Blood, C. H., and Zetter, B. R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta, 1032: 89-118, 1990.
26. Gimbrone, M. A., Jr., Leapman, S. B., Cotran, R. S., and Folkman, J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med., 136: 261-276, 1972.
27. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
28. Iwahana, M., Nakayama, Y., Tanaka, N. G., Goryo, M., and Okada, K. Quantification of tumor-induced angiogenesis by image analysis. Int. J. Exp. Pathol., 77: 109-114, 1996.
29. Niwa, H., Yamamura, K., and Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (Amst.), 108: 193-200, 1991.
30. Kimura, M., Takatsuki, A., and Yamaguchi, I. Blasticidin S deaminase from Aspergillus terreus (BSD): a new drug resistance gene for transfection of mammalian cells. Biochem. Biophys. Acta, 1219: 653-659, 1994.
31. Bossi, P., Viale, G., Lee, A. K. C., Alfano, R., Coggi, G., and Bosari, S. Angiogenesis in colorectal tumors: microvessel quantification in adenomas and carcinomas with clinicopathological correlations. Cancer Res., 55: 5049-5053, 1995.
32. Ishigami, S-I., Arii, S., Furutani, M., Niwano, M., Harada, T., Mizumoto, M., Mori, A., Onodera, H., and Imamura, M. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br. J. Cancer, 78: 1379-1384, 1998.
33. Kondo, Y., Arii, S., Funitani, M., Isigami, S-I., Mori, A., Onodera, H., Chiba, T., and Imamura, M. Implication of VEGF and p53 status for angiogenesis in non-invasive colorectal carcinoma. Cancer (Phila.), in press, 2000.
34. Durix, L. Y., Vermeulen, P. B., Hubens, G., Benoy, I., Martin, M., De Pooler, C., and Van Oosterom, A. T. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumor growth kinetics in advanced colorectal cancer. Ann. Oncol., 7: 843-848, 1996.
35. Durix, L. Y., Vermeulen, P. B., Hubens, G., Benoy, I., Martin, M., De Pooler, C., and Van Oosterom, A. T. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br. J. Cancer, 76: 238-243, 1997.
36. Landriscina, M., Cassano, A., Ratto, C., Longo, R., Ippoliti, M., Palazzotli, B., Crucitti, F., and Barone, C. Quantitative analysis of basic fibroblasl growlh factor and vascular endothelial growth factor in human colorectal cancer. Br. J. Cancer, 78: 765-770, 1998.
37. Kumar, H., Heer, K., Lee, P. W., Duthie, G. S., MacDonald, A. W., Greenman, J., Kerin, M. J., and Monson, J. R. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin. Cancer Res., 4: 1279-1285, 1998.
38. Fujisaki, K., Mitsuyama, K., Toyonaga, A., Matsuo, K., and Tanikawa, K. Circulating vascular endothelial growth factor in patients with colorectal cancer. Am. J. Gastroenterol., 93: 249-252, 1998.
39. Yoneda, J., Kuniyasu, H., Crispens, M. A., Price, J. E., Bucana, C. D., and Fidler, I. J. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst., 18: 447-454, 1998.
40. Luo, J. C., Yamaguchi, S., Shinkai, A., Shitara, K., and Shibuya, M. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors. Cancer Res., 58: 2652-2660, 1998.
41. Luo, J. C., Toyoda, M., and Shibuya, M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. Cancer Res., 58: 2594-2600, 1998.
42. Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marine, D., and Gastl, G. Vascular endothelial growth factor in the sera and effusion of patients with malignant and nonmalignant disease. Cancer (Phila.), 85: 178-187, 1999.
43. Nagy, J. A., Masse, E. M., Herzberg, K. T., Meyer, M. S., Yeo, K. T., Yeo, T. K., Sioussat, T. M., and Dvorak, H. F. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res., 55: 360-368, 1995.
44. Mesiano, S., Ferrara, N., and Jaffe, R. B. Role of vascular growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am. J. Pathol., 153: 1249-1256, 1998.